• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情防控措施限制了人们的接触,导致抗菌药物耐药率下降。

COVID-19 restrictions limited interactions of people and resulted in lowered antimicrobial resistance rates.

作者信息

Collignon Peter, Beggs John, Robson Jennifer

机构信息

Microbiology Department, ACT Pathology, Canberra Hospital, Garran, Australia.

Medical School, Australian National University, Canberra, Australia.

出版信息

JAC Antimicrob Resist. 2024 Aug 8;6(4):dlae125. doi: 10.1093/jacamr/dlae125. eCollection 2024 Aug.

DOI:10.1093/jacamr/dlae125
PMID:39119042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11306925/
Abstract

BACKGROUND

Antibiotic resistance is rising globally and is a major One Health problem. How much person-to-person transmission or 'contagion' contributes to the spread of resistant strains compared with antibiotic usage remains unclear. As part of its COVID-19 response, Australia introduced strict people movement restrictions in early 2020. Along with internal lockdown measures, movement of people into Australia from overseas was severely restricted. These circumstances provided a unique opportunity to examine the association of people movements with changes in resistance rates.

METHODS

Monthly resistance data on over 646 000 urine isolates from 2016 till 2023 were modelled for statistical changes in resistance trends during pre-lockdown, lockdown and post-lockdown periods. Data were available for three clinical contexts (community, hospital and aged-care facilities). Data were also available for antibiotic usage volumes and movements of people into Australia.

RESULTS

In 2020, arrivals into Australia decreased by >95%. Antibiotic community use fell by >20%. There were sharp falls in trend rates of resistance for all antibiotics examined after restrictions were instituted. This fall in trend rates of resistance persisted during restrictions. Notably, trend rates of resistance fell in all three clinical contexts. After removal of restrictions, an upsurge in trend rates of resistance was seen for nearly all antibiotics but with no matching upsurge in antibiotic use.

CONCLUSIONS

Restricting the movement of people appeared to have a dramatic effect on resistance rates in The resulting reduced person-to-person interactions seems more closely associated with changes in antibiotic resistance than antibiotic usage patterns.

摘要

背景

抗生素耐药性在全球范围内不断上升,是一个重大的“同一健康”问题。与抗生素使用相比,人际传播或“传染”在耐药菌株传播中所起的作用尚不清楚。作为应对新冠疫情的一部分,澳大利亚于2020年初实施了严格的人员流动限制措施。除了国内的封锁措施外,从海外进入澳大利亚的人员流动也受到严格限制。这些情况为研究人员流动与耐药率变化之间的关联提供了独特的机会。

方法

对2016年至2023年期间超过64.6万份尿液分离株的月度耐药数据进行建模,以分析封锁前、封锁期间和封锁后耐药趋势的统计变化。数据涵盖三种临床环境(社区、医院和老年护理机构)。同时也有抗生素使用量和进入澳大利亚的人员流动数据。

结果

2020年,进入澳大利亚的人数减少了95%以上。社区抗生素使用量下降了20%以上。在实施限制措施后,所有检测抗生素的耐药趋势率均大幅下降。这种耐药趋势率的下降在限制措施实施期间持续存在。值得注意的是,在所有三种临床环境中,耐药趋势率都有所下降。在解除限制后,几乎所有抗生素的耐药趋势率都出现了上升,但抗生素使用量并未相应增加。

结论

限制人员流动似乎对澳大利亚的耐药率产生了显著影响。由此减少的人际互动似乎比抗生素使用模式更紧密地与抗生素耐药性变化相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027e/11306925/842d6cc26c30/dlae125f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027e/11306925/d6e19267e181/dlae125f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027e/11306925/7882e74a358e/dlae125f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027e/11306925/c1fe84d92fdf/dlae125f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027e/11306925/842d6cc26c30/dlae125f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027e/11306925/d6e19267e181/dlae125f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027e/11306925/7882e74a358e/dlae125f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027e/11306925/c1fe84d92fdf/dlae125f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/027e/11306925/842d6cc26c30/dlae125f4.jpg

相似文献

1
COVID-19 restrictions limited interactions of people and resulted in lowered antimicrobial resistance rates.新冠疫情防控措施限制了人们的接触,导致抗菌药物耐药率下降。
JAC Antimicrob Resist. 2024 Aug 8;6(4):dlae125. doi: 10.1093/jacamr/dlae125. eCollection 2024 Aug.
2
The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia.新冠疫情公共卫生措施对澳大利亚监督注射设施就诊和过量用药的影响。
Public Health. 2023 Nov;224:90-97. doi: 10.1016/j.puhe.2023.08.019. Epub 2023 Sep 22.
3
Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling study.大流行 COVID-19 的附带影响推动了医院内抗生素耐药性的传播:一项建模研究。
PLoS Med. 2023 Jun 5;20(6):e1004240. doi: 10.1371/journal.pmed.1004240. eCollection 2023 Jun.
4
[The Change in Antimicrobial Resistance During the COVID-19 Pandemic in Türkiye].[土耳其2019年冠状病毒病大流行期间抗菌药物耐药性的变化]
Mikrobiyol Bul. 2023 Oct;57(4):507-534. doi: 10.5578/mb.20239943.
5
Trends in the Rates of Extended-Spectrum-β-Lactamase-Producing Isolated from Urine Cultures during the COVID-19 Pandemic in Ontario, Canada.加拿大安大略省 COVID-19 大流行期间尿液培养中产Extended-Spectrum-β-Lactamase 的分离株的流行率趋势。
Microbiol Spectr. 2023 Feb 14;11(1):e0312422. doi: 10.1128/spectrum.03124-22. Epub 2023 Jan 16.
6
Multi-year antimicrobial-resistance trends in urine Escherichia coli isolates from both community-based and hospital-based laboratories of an Australian local health district.澳大利亚某地方卫生区社区和医院实验室分离的尿大肠埃希氏菌的多年抗菌药物耐药趋势。
J Glob Antimicrob Resist. 2022 Dec;31:386-390. doi: 10.1016/j.jgar.2022.11.008. Epub 2022 Nov 25.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
Antimicrobial resistance of isolates from cattle in Eastern Algeria.阿尔及利亚东部牛群分离株的抗菌药物耐药性。
Vet World. 2019 Aug;12(8):1195-1203. doi: 10.14202/vetworld.2019.1195-1203. Epub 2019 Aug 7.
9
Lockdown Experiences and Views on Future Research Participation of Autistic Adults in the UK During the First 6 Months of the COVID-19 Pandemic.英国自闭症成年人在新冠疫情大流行前6个月的封锁经历及对未来研究参与的看法
Autism Adulthood. 2023 Sep 1;5(3):301-310. doi: 10.1089/aut.2022.0027. Epub 2023 Aug 30.
10
Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.从欧洲、美国、日本和澳大利亚皮肤科诊所痤疮患者中分离出的耐抗生素痤疮丙酸杆菌的表型和基因型特征。
Br J Dermatol. 2001 Feb;144(2):339-46. doi: 10.1046/j.1365-2133.2001.03956.x.

本文引用的文献

1
Impacts on Human Movement in Australian Cities Related to the COVID-19 Pandemic.与新冠疫情相关的澳大利亚城市中人类活动受到的影响。
Trop Med Infect Dis. 2023 Jul 14;8(7):363. doi: 10.3390/tropicalmed8070363.
2
The spread of antibiotic resistance to humans and potential protection strategies.抗生素耐药性向人类的传播及其潜在的保护策略。
Ecotoxicol Environ Saf. 2023 Apr 1;254:114734. doi: 10.1016/j.ecoenv.2023.114734. Epub 2023 Mar 10.
3
A parallel and silent emerging pandemic: Antimicrobial resistance (AMR) amid COVID-19 pandemic.
平行且无声的新兴大流行:COVID-19 大流行期间的抗微生物药物耐药性(AMR)。
J Infect Public Health. 2023 Apr;16(4):611-617. doi: 10.1016/j.jiph.2023.02.021. Epub 2023 Feb 21.
4
Persistence of resistance: a panel data analysis of the effect of antibiotic usage on the prevalence of resistance.耐药性的持续性:抗生素使用对耐药性流行影响的面板数据分析。
J Antibiot (Tokyo). 2023 May;76(5):270-278. doi: 10.1038/s41429-023-00601-6. Epub 2023 Feb 28.
5
Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis.COVID-19 患者的抗菌药物耐药性:系统评价和荟萃分析。
Lancet Microbe. 2023 Mar;4(3):e179-e191. doi: 10.1016/S2666-5247(22)00355-X. Epub 2023 Jan 31.
6
Sleeping with the enemy: Will the COVID-19 pandemic turn the tide of antimicrobial-resistant infections?与敌人共眠:新冠疫情会扭转抗微生物药物耐药性感染的趋势吗?
J Assoc Med Microbiol Infect Dis Can. 2021 Sep 30;6(3):177-180. doi: 10.3138/jammi-2021-05-28. eCollection 2021 Sep.
7
Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021).新冠病毒患者的抗菌药物耐药性:系统评价和荟萃分析(2019 年 11 月至 2021 年 6 月)。
Antimicrob Resist Infect Control. 2022 Mar 7;11(1):45. doi: 10.1186/s13756-022-01085-z.
8
Increasing incidence and antimicrobial resistance in Escherichia coli bloodstream infections: a multinational population-based cohort study.大肠杆菌血流感染的发病率和抗菌药物耐药性增加:一项多国家基于人群的队列研究。
Antimicrob Resist Infect Control. 2021 Sep 6;10(1):131. doi: 10.1186/s13756-021-00999-4.
9
Effect of antibiotic stewardship interventions in primary care on antimicrobial resistance of Escherichia coli bacteraemia in England (2013-18): a quasi-experimental, ecological, data linkage study.在初级保健中实施抗生素管理干预对英格兰大肠埃希菌菌血症的抗菌药物耐药性的影响(2013-18 年):一项准实验、生态、数据链接研究。
Lancet Infect Dis. 2021 Dec;21(12):1689-1700. doi: 10.1016/S1473-3099(21)00069-4. Epub 2021 Aug 4.
10
CON: COVID-19 will not result in increased antimicrobial resistance prevalence.反对观点:新型冠状病毒肺炎不会导致抗菌药物耐药性患病率上升。
JAC Antimicrob Resist. 2020 Sep;2(3):dlaa051. doi: 10.1093/jacamr/dlaa051. Epub 2020 Jul 17.